12 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp01292 | Aurein-1.3 | GLFDIIKKIAESF | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | MOLT-4 | Leukemia | IC50 : 4-5 μM |
| dbacp01992 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | MOLT-4 | Leukemia cancer | IC50 : 17 µg/ml |
| dbacp04608 | Maximin1 | GIGTKILGGVKTALKGALKELASTYAN | Yunnan firebelly toad | Not specified | MTT/MTS assay | MOLT-4 | Leukemia cancer | IC50 : 24.3 µg/ml |
| dbacp04612 | Maximin3 | GIGGKILSGLKTALKGAAKELASTYLH | Yunnan firebelly toad | Not specified | MTT/MTS assay | MOLT-4 | Leukemia cancer | IC50 : 25.2 µg/ml |
| dbacp04616 | Maximin4 | GIGVLLSAGKAALKGLAKVLAEKYAN | Yunnan firebelly toad | Not specified | MTT/MTS assay | MOLT-4 | Leukemia cancer | IC50 : 53.4 µg/ml |
| dbacp04620 | Maximin5 | SIGAKILGGVKTFFKGALKELASTYLQ | Yunnan firebelly toad | Not specified | MTT/MTS assay | MOLT-4 | Leukemia cancer | IC50 : >50 µg/ml |
| dbacp05322 | Peptide 5 | fCYwO-CyLeu-Pen-TKKrPKPfQwFwL-CyLeu-KKLMYPTYLKKfQWAV-Aib-HL | Synthetic peptide of four designed analogs of vasoactive intestinal peptide, bombesin | Not specified | MTT/MTS assay | MOLT-4 | Leukemia cancer | 10.4 % inhibition of cell proliferation at 1 nM |
| dbacp05323 | Peptide 5 | fCYwO-CyLeu-Pen-TKKrPKPfQwFwL-CyLeu-KKLMYPTYLKKfQWAV-Aib-HL | Synthetic peptide of four designed analogs of vasoactive intestinal peptide, bombesin | Not specified | MTT/MTS assay | MOLT-4 | Leukemia cancer | 18.7 % inhibition of cell proliferation at 10 nM |
| dbacp05324 | Peptide 5 | fCYwO-CyLeu-Pen-TKKrPKPfQwFwL-CyLeu-KKLMYPTYLKKfQWAV-Aib-HL | Synthetic peptide of four designed analogs of vasoactive intestinal peptide, bombesin | Not specified | MTT/MTS assay | MOLT-4 | Leukemia cancer | 34.7 % inhibition of cell proliferation at 100 nM |
| dbacp05325 | Peptide 5 | fCYwO-CyLeu-Pen-TKKrPKPfQwFwL-CyLeu-KKLMYPTYLKKfQWAV-Aib-HL | Synthetic peptide of four designed analogs of vasoactive intestinal peptide, bombesin | Not specified | MTT/MTS assay | MOLT-4 | Leukemia cancer | 54.3 % inhibition of cell proliferation at 1 µM |
| dbacp05326 | Peptide 5 | fCYwO-CyLeu-Pen-TKKrPKPfQwFwL-CyLeu-KKLMYPTYLKKfQWAV-Aib-HL | Synthetic peptide of four designed analogs of vasoactive intestinal peptide, bombesin | Not specified | MTT/MTS assay | MOLT-4 | Leukemia cancer | 94.5 % inhibition of cell proliferation at 10 µM |
| dbacp05330 | Peptide 5 | fCYwO-CyLeu-Pen-TKKrPKPfQwFwL-CyLeu-KKLMYPTYLKKfQWAV-Aib-HL | Synthetic peptide of four designed analogs of vasoactive intestinal peptide, bombesin | Not specified | MTT/MTS assay | MOLT-4 | Leukemia cancer | ED50 : 0.29 µM |